Financial Ratios PharmaCorp Rx Inc.

Stocks

PCRX

CA71714X1050

Drug Retailers

Market Closed - Toronto S.E. 01:23:15 10/09/2026 am IST			5-day change	1st Jan Change
0.4600 ^CAD	-1.08%		-3.16%	+1.10%

27/08	Pharmacorp Rx Inc. Announces Board and Committee Changes, Effective from August 31, 2026	CI
20/08	PharmaCorp Rx Swings to Q2 Profit as Revenue Jumps	MT

767d99.ZXJnrADrUrKNPqXYSynMnSRwGbnAMFEjwfarA-Cn2rU.OkcI82GROeigVsicOW-N3GkcQPe3VRxarYLjeabJi4MOPCXtZ7Ii-75WlQ

Published financial data: PHARMACORP RX INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021 (CAD)	2022 (CAD)	2023 (CAD)	2024 (CAD)	2025 (CAD)
Revenues	-	-	-	57.95L	2.09Cr
Total Revenues	-	-	-	57.95L	2.09Cr
Cost of Goods Sold, Total	-	-	-	36.11L	1.26Cr
Gross Profit	-	-	-	21.84L	82.98L
Selling General & Admin Expenses, Total	79.6T	2L	6L	32L	81.9L
Stock-Based Compensation (IS)	-	4L	-	3L	4L
Depreciation & Amortization - (IS)	-	-	-	3L	9L
Other Operating Expenses, Total	79.6T	6L	6L	37.73L	95.36L
Operating Income	-79.6T	-6L	-6L	-15.88L	-12.38L
Interest Expense, Total	-	-	-	-14.26T	-56.86T
Interest And Investment Income	2.14T	46.09T	1L	4L	3L
Net Interest Expenses	2.14T	46.09T	1L	4L	2L
Other Non Operating Income (Expenses)	-	-	-	63.96T	2L
EBT, Excl. Unusual Items	-77.45T	-5L	-5L	-11.57L	-8L
EBT, Incl. Unusual Items	-77.45T	-5L	-5L	-11.57L	-8L
Income Tax Expense	-	-	-	-1L	6L
Earnings From Continuing Operations	-77.45T	-5L	-5L	-10.51L	-14.22L
Net Income to Company	-77.45T	-5L	-5L	-10.51L	-14.22L
Minority Interest	-	-	-	38.11T	-59.3T
Net Income - (IS)	-77.45T	-5L	-5L	-10.13L	-14.81L
Net Income to Common Incl Extra Items	-77.45T	-5L	-5L	-10.13L	-14.81L
Net Income to Common Excl. Extra Items	-77.45T	-5L	-5L	-10.13L	-14.81L
Per Share Items
Net EPS - Basic	-	-0.03	-0.02	-0.01	-0.01
Basic EPS - Continuing Operations	-	-0.03	-0.02	-0.01	-0.01
Basic Weighted Average Shares Outstanding	1.62Cr	2Cr	2.03Cr	8.17Cr	13Cr
Net EPS - Diluted	-	-0.03	-0.02	-0.01	-0.01
Diluted EPS - Continuing Operations	-	-0.03	-0.02	-0.01	-0.01
Diluted Weighted Average Shares Outstanding	1.62Cr	2Cr	2.03Cr	8.17Cr	13Cr
Normalized Basic EPS	-	-0.02	-0.01	-0.01	-0
Normalized Diluted EPS	-	-0.02	-0.01	-0.01	-0
Supplemental Items
EBITDA	-	-	-	-13.46L	-4L
EBITA	-79.6T	-6L	-6L	-14.16L	-6L
EBIT	-79.6T	-6L	-6L	-15.88L	-12.38L
Total Revenues (As Reported)	2.14T	46.09T	1L	-	-
Effective Tax Rate - (Ratio)	-	-	-	9.2	-70.14
Total Current Taxes	-	-	-	31.19T	7L
Total Deferred Taxes	-	-	-	-1L	-1L
Normalized Net Income	-48.41T	-3L	-3L	-7L	-6L
Interest on Long-Term Debt	-	-	-	32.43T	63.95T
Supplemental Operating Expense Items
General and Administrative Expenses	79.6T	2L	6L	18.83L	33.12L
Stock-Based Comp., Other (Total)	-	4L	-	3L	4L
Total Stock-Based Compensation	-	4L	-	3L	4L

Fiscal Period: December	2021 (CAD)	2022 (CAD)	2023 (CAD)	2024 (CAD)	2025 (CAD)
Assets
Cash And Equivalents	10L	27.33L	22.42L	1.29Cr	2.59Cr
Total Cash And Short Term Investments	10L	27.33L	22.42L	1.29Cr	2.59Cr
Accounts Receivable, Total	-	-	-	3L	12.18L
Total Receivables	-	-	-	3L	12.18L
Inventory	-	-	-	13.13L	27.05L
Prepaid Expenses	-	-	-	48.03T	80.85T
Other Current Assets, Total	20.5T	-	78.75T	-	-
Total Current Assets	10.01L	27.33L	23.21L	1.46Cr	2.99Cr
Gross Property Plant And Equipment	-	-	-	41.42L	57.17L
Accumulated Depreciation	-	-	-	-1L	-2L
Net Property Plant And Equipment	-	-	-	40.25L	54.81L
Goodwill	-	-	-	1.15Cr	1.86Cr
Other Intangibles, Total	-	-	-	51.34L	1.16Cr
Total Assets	10.01L	27.33L	23.21L	3.52Cr	6.56Cr
Liabilities
Accounts Payable, Total	26.34T	16.46T	46.18T	15.36L	52.03L
Current Portion of Long-Term Debt	-	-	-	75.41T	4L
Current Portion of Leases	-	-	-	73.97T	2L
Current Income Taxes Payable	-	-	-	10.52T	62.47T
Total Current Liabilities	26.34T	16.46T	46.18T	16.96L	58.1L
Long-Term Debt	-	-	-	3L	30.89L
Long-Term Leases	-	-	-	5L	9L
Deferred Tax Liability Non Current	-	-	-	21.43L	34.9L
Total Liabilities	26.34T	16.46T	46.18T	46.43L	1.33Cr
Common Stock, Total	10L	27.43L	27.99L	3.17Cr	5.1Cr
Additional Paid In Capital	-	5L	5L	7L	20.07L
Retained Earnings	-25.82T	-5L	-10.13L	-20.26L	-31.42L
Comprehensive Income and Other	-	-	-	-	21.06L
Total Common Equity	10L	27.17L	22.74L	3.03Cr	5.19Cr
Minority Interest	-	-	-	2L	3L
Total Equity	10L	27.17L	22.74L	3.06Cr	5.23Cr
Total Liabilities And Equity	10.01L	27.33L	23.21L	3.52Cr	6.56Cr
Supplemental Items
ECS Total Shares Outstanding on Filing Date	1.62Cr	2Cr	2.03Cr	12Cr	17Cr
ECS Total Common Shares Outstanding	1.62Cr	2Cr	2.03Cr	12Cr	17Cr
Book Value / Share	0.06	0.14	0.11	0.26	0.3
Tangible Book Value	10L	27.17L	22.74L	1.37Cr	2.17Cr
Tangible Book Value Per Share	0.06	0.14	0.11	0.12	0.12
Total Debt	0	0	0	10L	45.45L
Net Debt	-10L	-27.33L	-22.42L	-1.19Cr	-2.13Cr
Minority Interest, Total (Incl. Fin. Div)	-	-	-	2L	3L
Account Code - Inventory Valuation	3	3	3	6	6
Inventories - Raw Materials, Total	-	-	-	44.25T	47.64T
Inventories - Others	-	-	-	12.69L	26.58L
Land - (BS)	-	-	-	2L	4L
Buildings, Total	-	-	-	28.45L	37.03L
Machinery, Total	-	-	-	1L	3L
Full Time Employees	-	-	-	-	5

Fiscal Period: December	2021 (CAD)	2022 (CAD)	2023 (CAD)	2024 (CAD)	2025 (CAD)
Net Income	-77.45T	-5L	-5L	-10.13L	-14.81L
Depreciation & Amortization - CF	-	-	-	1L	3L
Amortization of Goodwill and Intangible Assets - (CF)	-	-	-	2L	7L
Depreciation & Amortization, Total	-	-	-	3L	9L
Stock-Based Compensation (CF)	-	4L	-	3L	4L
Other Operating Activities, Total	-	-	-	-1L	16.55T
Change In Accounts Receivable	-	-	-	-538	-1L
Change In Inventories	-	-	-	1L	-3L
Change In Accounts Payable	79.03T	-9.88T	29.72T	5L	22.71L
Change In Income Taxes	-	-	-	2.92T	3L
Change in Other Net Operating Assets	-	20.5T	-78.75T	95.97T	46.25T
Cash from Operations	1.58T	-1L	-5L	1L	20.06L
Capital Expenditure	-	-	-	-6.89T	-87.6T
Cash Acquisitions	-	-	-	-1.69Cr	-1.05Cr
Sale (Purchase) of Intangible assets	-	-	-	-	-20.9L
Other Investing Activities, Total	-	-	-	-	-10.19L
Cash from Investing	-	-	-	-1.69Cr	-1.37Cr
Long-Term Debt Issued, Total	-	-	-	-	31.63L
Total Debt Issued	-	-	-	-	31.63L
Long-Term Debt Repaid, Total	-	-	-	-1L	-3L
Total Debt Repaid	-	-	-	-1L	-3L
Issuance of Common Stock	30L	20L	27.84T	2.75Cr	2.14Cr
Other Financing Activities, Total	-61.5T	-1L	-	-	4L
Cash from Financing	29.38L	18.74L	27.84T	2.74Cr	2.47Cr
Net Change in Cash	29.4L	17.53L	-5L	1.06Cr	1.3Cr
Supplemental Items
Levered Free Cash Flow	-	44.92T	-4L	-5L	-2L
Unlevered Free Cash Flow	-	44.92T	-4L	-5L	-2L
Change In Net Working Capital	-	-10.62T	49.03T	1L	-14.02L
Net Debt Issued / Repaid	-	-	-	-1L	28.4L

Fiscal Period: December	2021 (CAD)	2022 (CAD)	2023 (CAD)	2024 (CAD)	2025 (CAD)
Profitability
Return on Assets	-	-18.85	-14.29	-5.29	-1.54
Return on Total Capital	-	-19.07	-14.47	-5.88	-1.75
Return On Equity %	-	-28.02	-18.85	-6.4	-3.43
Return on Common Equity	-	-28.02	-18.85	-6.21	-3.6
Margin Analysis
Gross Profit Margin %	-	-	-	37.69	39.72
SG&A Margin	-	-	-	55.22	39.2
EBITDA Margin %	-	-	-	-23.23	-1.98
EBITA Margin %	-	-	-	-24.44	-2.78
EBIT Margin %	-	-	-	-27.41	-5.92
Income From Continuing Operations Margin %	-	-	-	-18.14	-6.81
Net Income Margin %	-	-	-	-17.48	-7.09
Net Avail. For Common Margin %	-	-	-	-17.48	-7.09
Normalized Net Income Margin	-	-	-	-11.83	-2.78
Levered Free Cash Flow Margin	-	-	-	-9.39	-1.14
Unlevered Free Cash Flow Margin	-	-	-	-9.23	-0.97
Asset Turnover
Asset Turnover	-	-	-	0.31	0.41
Fixed Assets Turnover	-	-	-	-	4.4
Receivables Turnover (Average Receivables)	-	-	-	-	27.05
Inventory Turnover (Average Inventory)	-	-	-	-	6.27
Short Term Liquidity
Current Ratio	37.98	166.01	50.24	8.59	5.14
Quick Ratio	37.2	166.01	48.54	7.79	4.67
Operating Cash Flow to Current Liabilities	0.06	-7.3	-11.25	0.07	0.35
Days Sales Outstanding (Average Receivables)	-	-	-	-	13.49
Days Outstanding Inventory (Average Inventory)	-	-	-	-	58.22
Average Days Payable Outstanding	-	-	-	-	87.92
Cash Conversion Cycle (Average Days)	-	-	-	-	-16.21
Long Term Solvency
Total Debt/Equity	-	-	-	3.12	8.7
Total Debt / Total Capital	-	-	-	3.02	8
LT Debt/Equity	-	-	-	2.63	7.65
Long-Term Debt / Total Capital	-	-	-	2.55	7.04
Total Liabilities / Total Assets	2.63	0.6	1.99	13.19	20.28
EBIT / Interest Expense	-	-	-	-111.38	-21.77
EBITDA / Interest Expense	-	-	-	-91.06	-5.23
(EBITDA - Capex) / Interest Expense	-	-	-	-91.54	-6.77
Total Debt / EBITDA	-	-	-	-0.73	-15.28
Net Debt / EBITDA	-	-	-	9.19	71.73
Total Debt / (EBITDA - Capex)	-	-	-	-0.73	-11.8
Net Debt / (EBITDA - Capex)	-	-	-	9.14	55.41
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-	-	-	-	260.57
Gross Profit, 1 Yr. Growth %	-	-	-	-	279.89
EBITDA, 1 Yr. Growth %	-	-	-	-	-69.19
EBITA, 1 Yr. Growth %	-	607.52	2.62	145.02	-59
EBIT, 1 Yr. Growth %	-	607.52	2.62	174.82	-22.08
Earnings From Cont. Operations, 1 Yr. Growth %	-	567.6	-9.02	123.4	35.31
Net Income, 1 Yr. Growth %	-	567.6	-9.02	115.3	46.26
Normalized Net Income, 1 Yr. Growth %	-	567.6	-9.02	133.07	-15.12
Diluted EPS Before Extra, 1 Yr. Growth %	-	-	-10.27	-46.58	-4.49
Accounts Receivable, 1 Yr. Growth %	-	-	-	-	272.71
Inventory, 1 Yr. Growth %	-	-	-	-	106.02
Net Property, Plant and Equip., 1 Yr. Growth %	-	-	-	-	36.19
Total Assets, 1 Yr. Growth %	-	173.19	-15.1	1.42T	86.23
Tangible Book Value, 1 Yr. Growth %	-	178.89	-16.29	503.86	58.16
Common Equity, 1 Yr. Growth %	-	178.89	-16.29	1.23T	71.11
Cash From Operations, 1 Yr. Growth %	-	-7.73T	332.22	-124.06	1.51T
Capital Expenditures, 1 Yr. Growth %	-	-	-	-	1.17T
Levered Free Cash Flow, 1 Yr. Growth %	-	-	-1.01T	32.59	-56.17
Unlevered Free Cash Flow, 1 Yr. Growth %	-	-	-1.01T	30.42	-62.08
Compound Annual Growth Rate Over Two Years
EBITA, 2 Yr. CAGR %	-	-	169.46	58.57	0.23
EBIT, 2 Yr. CAGR %	-	-	169.46	67.94	46.34
Earnings From Cont. Operations, 2 Yr. CAGR %	-	-	146.45	42.56	73.86
Net Income, 2 Yr. CAGR %	-	-	146.45	39.95	77.45
Normalized Net Income, 2 Yr. CAGR %	-	-	146.45	45.61	40.65
Diluted EPS Before Extra, 2 Yr. CAGR %	-	-	-	-30.77	-28.57
Total Assets, 2 Yr. CAGR %	-	-	52.29	258.9	431.57
Tangible Book Value, 2 Yr. CAGR %	-	-	52.79	124.83	209.05
Common Equity, 2 Yr. CAGR %	-	-	52.79	234.19	377.8
Cash From Operations, 2 Yr. CAGR %	-	-	1.72T	1.97	96.53
Levered Free Cash Flow, 2 Yr. CAGR %	-	-	-	248.01	-23.76
Unlevered Free Cash Flow, 2 Yr. CAGR %	-	-	-	245.15	-29.67
Compound Annual Growth Rate Over Three Years
EBITA, 3 Yr. CAGR %	-	-	-	161.05	1.02
EBIT, 3 Yr. CAGR %	-	-	-	171.23	30.01
Earnings From Cont. Operations, 3 Yr. CAGR %	-	-	-	138.51	40.1
Net Income, 3 Yr. CAGR %	-	-	-	135.59	42.03
Normalized Net Income, 3 Yr. CAGR %	-	-	-	141.9	21.64
Diluted EPS Before Extra, 3 Yr. CAGR %	-	-	-	-	-22.93
Total Assets, 3 Yr. CAGR %	-	-	-	227.7	188.4
Tangible Book Value, 3 Yr. CAGR %	-	-	-	141.57	99.96
Common Equity, 3 Yr. CAGR %	-	-	-	214.64	167.36
Cash From Operations, 3 Yr. CAGR %	-	-	-	329.71	155.58
Levered Free Cash Flow, 3 Yr. CAGR %	-	-	-	-	74.45
Unlevered Free Cash Flow, 3 Yr. CAGR %	-	-	-	-	65.31